ft 23 jul 92 survey pharmaceut 2 challeng speed invent curb cost r amp pharmaceut laboratori come mani shape size grandest pound 500m research centr construct glaxo stevenag 30 mile north london glaxo lab said largest build project uk channel tunnel hous 1 400 research open 1994 mani scientist work togeth one site give access best possibl rang expens date equip danger howev bureaucraci smother imagin approach essenti develop innov drug glaxo tri overcom clever research manag make scientist feel work small unit opposit school thought research flourish best genuin small group illustr scotia pharmaceut emerg uk compani specialis drug base essenti fatti acid scotia 170 employe altogeth yet carri research develop six wide separ site callanish isl lewi outer hebrid dunde east coast scotland carlisl north west england writtl essex guildford surrey nova scotia canada dr iain law charg r amp callanish sure remot pharmaceut laboratori europ say keep good touch facil visit colleagu weekli note written scotia r amp manag circul around compani pharmaceut lab whatev size locat face common challeng restrain soar cost r amp time speed discoveri develop new drug accord data collect centr medicin research uk worldwid spend pharmaceut r amp increas averag 16 per cent year 1980 global total reach dollar 24bn 1990 15 per cent pharmaceut sale almost half industri r amp expenditur europ 36 per cent us 15 per cent japan unfortun rapid rise r amp spend produc correspond increas flow new drug onto market number medicin launch earli 1980 averag 60 per year three year 1989 91 close 40 year number new drug origin europ fallen decad 30 40 year 10 20 year total time taken develop new drug increas steadili sinc 1960 clinic phase test drug human patient doubl 1980 reach averag seven year trial take longer regulatori author requir clinic data doctor patient becom reluct take part compani spend time money recruit hundr even thousand peopl requir test drug industri respond two main way lobbi author reduc regulatori burden oper r amp effort effici one way eas regulatori burden harmonis requir around world compani repeat test unnecessarili satisfi author differ countri alreadi happen within europ ec global level first intern confer harmonis brussel last novemb import step toward bring us japan europ line agre exampl routin 12 month toxic test anim abandon favour six month studi much need done particularli harmonis clinic requir complet standardis unattain medic practic social condit vari much around world ultim object retain differ justifi ration criteria time compani tri improv product research particularli pre clinic phase control close clinic trial invest heavili new technolog rang computeris chemic databas molecular model graphic automat gene sequenc machin help scientist select adapt compound rapidli drug develop besid introduc new technolog industri chang way manag r amp good uk exampl ici pharmaceut redesign approach get fastest possibl answer question drug behav human way would predict laboratori model say dr tom mckillop technic director ici consist achiev target administ candid drug human volunt within 14 month first synthesi great improv compani previou averag perform 30 month time ici much ruthless abandon compound live initi promis dr mckillop say new regim quit differ ici tradit approach assum everi drug go succeed